Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic

Jacqueline D Peda1, Sally M Salah2, Darren P Wallace3

  • 1Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA Kidney Institute, University of Kansas Medical Center, Kansas City, KS 66160, USA.

Insights

Polycystic kidney disease (PKD) involves macrophages promoting cyst growth. Blocking IL-10 signaling in macrophages could be a new therapeutic strategy for PKD.

Area of Science:

  • Nephrology
  • Immunology
  • Cell Biology

Background:

  • Polycystic kidney disease (PKD) is a genetic disorder characterized by kidney cyst formation and growth.
  • Macrophages play a critical role in PKD progression by promoting cyst epithelial cell proliferation and expansion.
  • Cystic epithelial cells can 'program' macrophages, inducing an M2-like polarization.

Purpose of the Study:

  • To functionally characterize M2-like macrophages in PKD.
  • To investigate the role of IL-10 in the pathological macrophage phenotype in PKD.
  • To explore the IL-10-STAT3 pathway in macrophage-mediated cyst growth.

Main Methods:

  • Functional characterization of M2-like macrophages.
  • Investigation of IL-10 secretion by macrophages.
  • Analysis of IL-10-dependent STAT3 pathway activation.

Main Results:

  • M2-like macrophages derived from PKD cysts enhance cyst cell proliferation.
  • IL-10 secretion by macrophages is essential for acquiring this pathological phenotype.
  • Autocrine activation of the STAT3 pathway via IL-10 is required for macrophage-driven cyst growth.

Conclusions:

  • A reciprocal pathological interaction exists between cyst epithelial cells and macrophages in PKD.
  • The IL-10-STAT3 pathway in macrophages is crucial for PKD pathogenesis.
  • Targeting the IL-10 pathway in macrophages represents a potential therapeutic strategy for PKD.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K